Spondyloarthritis: An expanding cast of cellular actors.

[1]  T. Ndung’u,et al.  The role of mucosal‐associated invariant T cells in infectious diseases , 2017, Immunology.

[2]  M. Chimenti,et al.  Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis. , 2016, Clinical and experimental rheumatology.

[3]  M. Kusaoi,et al.  Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis , 2016, The Journal of Rheumatology.

[4]  S. Raimondo,et al.  Interleukin‐9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis , 2016, Arthritis & rheumatology.

[5]  G. Guggino,et al.  Interleukin‐9 and T helper type 9 cells in rheumatic diseases , 2016, Clinical and experimental immunology.

[6]  D. Elewaut,et al.  MAIT cells: not just another brick in the wall , 2016, Annals of the rheumatic diseases.

[7]  D. Wendling.  The gut in spondyloarthritis. , 2016, Joint, bone, spine : revue du rhumatisme.

[8]  A. Chhabra,et al.  Ankylosing Spondylitis and Axial Spondyloarthritis. , 2016, The New England journal of medicine.

[9]  Y. Baglaenko,et al.  IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis , 2016, Annals of the rheumatic diseases.

[10]  T. Korn,et al.  Interleukin‐23–Dependent γ/δ T Cells Produce Interleukin‐17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice , 2016, Arthritis & rheumatology.

[11]  K. Venken,et al.  New immune cells in spondyloarthritis: Key players or innocent bystanders? , 2015, Best practice & research. Clinical rheumatology.

[12]  D. Artis,et al.  Innate lymphoid cells in the initiation, regulation and resolution of inflammation , 2015, Nature Medicine.

[13]  D. Dumitrascu,et al.  Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. , 2015, World journal of gastroenterology.

[14]  G. Sireci,et al.  Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis , 2015, Annals of the rheumatic diseases.

[15]  D. M. van der Heijde,et al.  IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. , 2015, Rheumatology.

[16]  H. Spits,et al.  The biology of innate lymphoid cells , 2015, Nature.

[17]  J. Berthelot,et al.  Essential role for CD103+ cells in the pathogenesis of spondyloarthritides. , 2015, Joint, bone, spine : revue du rhumatisme.

[18]  C. Prati,et al.  The IL-23/Th 17 pathway in spondyloarthritis: the royal road? , 2015, Joint, bone, spine : revue du rhumatisme.

[19]  L. Cosmi,et al.  Th17 plasticity: pathophysiology and treatment of chronic inflammatory disorders. , 2014, Current opinion in pharmacology.

[20]  D. Hafler,et al.  The plasticity of human Treg and Th17 cells and its role in autoimmunity. , 2013, Seminars in immunology.

[21]  T. Mcclanahan,et al.  IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.

[22]  A. Rizzo,et al.  Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. , 2012, Arthritis and rheumatism.

[23]  H. Hammad,et al.  Invariant natural killer T cells are natural regulators of murine spondylarthritis. , 2010, Arthritis and rheumatism.